Your browser doesn't support javascript.
loading
Immunotherapy for lymphoma / 国际肿瘤学杂志
Article en Zh | WPRIM | ID: wpr-659116
Biblioteca responsable: WPRO
ABSTRACT
At present,immunotherapies for lymphoma are becoming gradually important.Chimeric antigen receptor-modified T cells therapy,bispecific antibody and immune-checkpoint inhibitor are considered as breakthrough treatments,each has its own unique mechanism,and more advanced treatments will be developed based on them.
Palabras clave
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Journal of International Oncology Año: 2017 Tipo del documento: Article
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Journal of International Oncology Año: 2017 Tipo del documento: Article